BioMedPartners

BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.